Alphabet’s Verily life sciences company lands $800M investment from Temasek

Alphabet’s health-focused subsidiary Verily, formerly Google Life Sciences before the great corporate alphabetization, has received an $800 million investment from Temasek, the majority of which is to be delivered mostly over the next few days, with a smaller portion of funding coming in the second half of 2017. Temasek is an investment company based in Singapore, with investments across a wide range of industries and global offices around the world.

Global HPV Testing Market 2016-2020; New Report Launched

According to Centers for Disease Control and Prevention , human papillomavirus refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals.

Islets from rat-grown mouse pancreases can help reverse disease in diabetic mice

Mouse pancreases grown in rats generate functional, insulin-producing cells that can reverse diabetes when transplanted into mice with the disease, according to researchers at the Stanford University School of Medicine and the Institute of Medical Science at the University of Tokyo. The recipient animals required only days of immunosuppressive therapy to prevent rejection of the genetically matched rather than lifelong treatment.

Islets from rat-grown mouse pancreases can help reverse disease in diabetic mice

Mouse pancreases grown in rats generate functional, insulin-producing cells that can reverse diabetes when transplanted into mice with the disease, according to researchers at the Stanford University School of Medicine and the Institute of Medical Science at the University of Tokyo. The recipient animals required only days of immunosuppressive therapy to prevent rejection of the genetically matched rather than lifelong treatment.

In utero environment can impact brain development, study shows

A new study shows that what happens to a fetus in the womb can affect the brain later in life. In a paper recently published in Human Brain Mapping , a team of researchers from the Quebec-based Research Unit on Children’s Psychosocial Maladjustment shows how the in utero environment can play a role in the development of brain processes.

3 Stocks Dominating the Future of Healthcare

The healthcare sector is undergoing a revolution of sorts due to the advent of several game-changing new technologies, medical devices, and pharmaceutical products. To help investors get a grasp on this technologically fueled shift in healthcare, we asked three of our contributors to discuss which changes they think are the most critical to watch right now.

3 Stocks Dominating the Future of Healthcare

The healthcare sector is undergoing a revolution of sorts due to the advent of several game-changing new technologies, medical devices, and pharmaceutical products. To help investors get a grasp on this technologically fueled shift in healthcare, we asked three of our contributors to discuss which changes they think are the most critical to watch right now.

Ritter Pharmaceuticals Announces Collaboration with University of…

As part of the collaboration, Dr. Amanda Ramer-Tait at NU and Jens Walter, University of Alberta, two leading scientists in the fields of gut health and microbiome research, plan to conduct research exploring the microbiome’s role in metabolic syndrome. The pre-clinical research is designed to build upon previously published studies suggesting that prebiotics may support improvements in clinical measurements associated with metabolic syndrome.

Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson’s disease.

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. In recent years, CHCHD2 and CHCHD10 mutations were reported to be associated with a broad spectrum of neurodegenerative diseases, including Parkinson’s disease , although with conflicting results in different populations.

Anavex Life Sciences Receives Grant From Rettsyndrome.org to Commence U.S. Phase 2 Trial in 2017

Anavex Life Sciences Corp. and the International Rett Syndrome Foundation, doing business as Rettsyndrome.org today announced that Rettsyndrome.org has committed a financial grant of a minimum of $0.6 million to cover the majority of a planned U.S. multicenter Phase 2 clinical trial of ANAVEX 2-73 for the treatment of Rett syndrome. Scheduled to begin in 2017, the trial will be a randomized, double blind, placebo-controlled study of ANAVEX 2-73 in patients with Rett syndrome lasting up to 12 weeks.

Researchers discover genetic fingerprint identifying how prostate cancer spreads

Canadian researchers have identified a genetic fingerprint that explains why up to almost a third of men with potentially curable localized prostate cancer develop aggressive disease that spreads following initial treatment. Co-principal investigator Dr. Robert Bristow of Toronto’s Princess Margaret Cancer Centre says the discovery could help doctors personalize more effective, targeted therapies from the moment a man is diagnosed with prostate cancer.

Prostate cancer genetics could aid cure: study

Canadian researchers have identified a genetic fingerprint that explains why up to almost a third of men with potentially curable localized prostate cancer develop aggressive disease that spreads following initial treatment. Co-principal investigator Dr. Robert Bristow of Toronto’s Princess Margaret Cancer Centre says the discovery could help doctors personalize more effective, targeted therapies from the moment a man is diagnosed with prostate cancer.

Birth control requests rise ahead of Trump

… time and earning her college degree in genetics when she got a serious boyfriend. Thompson sought care at the campus health clinic, where she chose a hormone implant under her skin that prevents pregnancy for up to thee years. ST. LOUIS – Angelica …

Better Buy: Alnylam Pharmaceuticals vs. Ionis Pharmaceuticals

Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals In 2016, these two stocks have taken paths as varied as their approaches to drug development, and the past few months have been a wild ride.

Why More Women Get These Diseases Than Men

Nearly 80% of people who suffer from autoimmune diseases are women, and why that’s the case has long been a medical mystery. But new research suggests the answer may have to do with differences between men’s and women’s genes – a discovery that could pave the way for better diagnostic methods and treatments in the future.

Anthera’s cystic fibrosis drug fails late-stage study, shares tank

REUTERS: Anthera Pharmaceuticals Inc said on Tuesday that its drug to treat certain cystic fibrosis patients failed a late-stage study, sending the company’s shares tumbling nearly 70 percent in after-hours trading. The latest setback for Anthera comes just over a month after the company said an experimental drug to treat lupus had also failed in a late-stage study.

New treatments, new mental health focus for diabetes

Upgrading the standard of care for diabetes, the American Diabetes Association now recommends a stronger focus on mental health problems associated with diabetes, a lower body mass index level to qualify for bariatric surgery, and the reporting of low blood sugar levels to physicians. On Dec. 15, the association released two important reports – 2017 Standards of Medical Care in Diabetes” and a consensus report on “Differentiation of Diabetes by Pathophysiology, Natural History and Prognosis.”